Drug delivery in aortic valve tissue engineering

Journal of Controlled Release

Volumn 196, Issue , 2014, Pages 307-323

  Jana, Soumen ^a   Simari, Robert D ^b   Spoon, Daniel B ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Drug delivery; Fiber; Heart valve; Hydrogel; Scaffold; Tissue engineering

Indexed keywords

FIBERS; HYDROGELS; SCAFFOLDS; TISSUE ENGINEERING;

AORTIC VALVES; HEART VALVES;

DRUG DELIVERY;

ALGINIC ACID; AMINE; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; CHONDROITIN SULFATE; COLLAGEN; DRUG CARRIER; FIBRIN; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GELATIN; HYALURONIC ACID; HYDROXYAPATITE; HYDROXYL GROUP; MICROSPHERE; NANOFIBER; NANOPARTICLE; PLATELET DERIVED GROWTH FACTOR; POLYESTER; POLYGLACTIN; POLYGLYCOLIC ACID; POLYHYDROXYALKANOIC ACID; POLYLACTIC ACID; POLYMER; POLYSACCHARIDE; PROTEIN; REAGENT; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANTIGEN PRESENTING CELL; AORTA VALVE; AORTA VALVE DISEASE; BONE MARROW PROGENITOR CELL; DENDRITIC CELL; DRUG DELIVERY SYSTEM; ENDOTHELIAL PROGENITOR CELL; HEART CATHETERIZATION; HYDROGEL; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; TISSUE ENGINEERING; TISSUE SCAFFOLD; ANATOMY AND HISTOLOGY; ANIMAL; AORTIC VALVE INSUFFICIENCY; DRUG DESIGN; HUMAN; PROCEDURES;

ANIMALS; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; TISSUE ENGINEERING;

EID: 84908576516     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.10.009     Document Type: Review

References (258)

1. T. Treasure Rethink on biological aortic valves for the elderly Lancet 354 1999 964 965
2. I. El-Hamamsy, Z. Eryigit, L.M. Stevens, Z. Sarang, R. George, L. Clark, G. Melina, J.J. Takkenberg, and M.H. Yacoub Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial Lancet 376 2010 524 531
3. J.L. d'Arcy, B.D. Prendergast, J.B. Chambers, S.G. Ray, and B. Bridgewater Valvular heart disease: the next cardiac epidemic Heart 97 2011 91 93
4. D. Messika-Zeitoun, L.F. Bielak, P.A. Peyser, P.F. Sheedy, S.T. Turner, V.T. Nkomo, J.F. Breen, J. Maalouf, C. Scott, A.J. Tajik, and M. Enriquez-Sarano Aortic valve calcification: determinants and progression in the population Arterioscler. Thromb. Vasc. Biol. 27 2007 642 648
5. A. Mol, A.I.P.M. Smits, C.V.C. Bouten, and F.P.T. Baaijens Tissue engineering of heart valves: advances and current challenges Expert Rev. Med. Devices 6 2009 259 275
6. B. Remenyi, N. Wilson, A. Steer, B. Ferreira, J. Kado, K. Kumar, J. Lawrenson, G. Maguire, E. Marijon, M. Mirabel, A.O. Mocumbi, C. Mota, J. Paar, A. Saxena, J. Scheel, J. Stirling, S. Viali, V.I. Balekundri, G. Wheaton, L. Zuhlke, and J. Carapetis World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease - an evidence-based guideline Nat. Rev. Cardiol. 9 2012 297 309
7. J.T. Butcher, G.J. Mahler, and L.A. Hockaday Aortic valve disease and treatment: the need for naturally engineered solutions Adv. Drug Deliv. Rev. 63 2011 242 268
8. N.A. Boon, and P. Bloomfield The medical management of valvar heart disease Heart 87 2002 395 400
9. M.H. Yacoub, and J.J. Takkenberg Will heart valve tissue engineering change the world? Nat. Clin. Pract. Cardiovasc. Med. 2 2005 60 61
10. P. Kvidal, R. Bergstrom, L.G. Horte, and E. Stahle Observed and relative survival after aortic valve replacement J. Am. Coll. Cardiol. 35 2000 747 756
11. S. Basude, C. Hein, S.L. Curtis, A. Clark, and J. Trinder Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study Bjog-an Int. J. Obstet. Gynaecol. 119 2012 1008 1013
12. K. Hammermeister, G.K. Sethi, W.G. Henderson, F.L. Grover, C. Oprian, and S.H. Rahimtoola Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial J. Am. Coll. Cardiol. 36 2000 1152 1158
13. P.M. Dohmen, and W. Konertz Tissue-engineered heart valve scaffolds Ann. Thorac. Cardiovasc. Surg. 15 2009 362 367
14. M.N. Tillquist, and T.M. Maddox Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement Patient Prefer. Adherence 5 2011 91 99
15. C.V.C. Bouten, P.Y.W. Dankers, A. Driessen-Mol, S. Pedron, A.M.A. Brizard, and F.P.T. Baaijens Substrates for cardiovascular tissue engineering Adv. Drug Deliv. Rev. 63 2011 221 241
16. E.J. Armstrong, and J. Bischoff Heart valve development - endothelial cell signaling and differentiation Circ. Res. 95 2004 459 470
17. Y. Tabata The importance of drug delivery systems in tissue engineering Pharm. Sci. Technol. Today 3 2000 80 89
18. H. Kim, R. Bergman, R. Matyal, K.R. Khabbaz, and F. Mahmood Three-dimensional echocardiography and en face views of the aortic valve: technical communication J. Cardiothorac. Vasc. Anesth. 27 2013 376 380
19. S.J. Choo, G. McRae, J.P. Olomon, G. St George, W. Davis, C.L. Burleson-Bowles, D. Pang, H.H. Luo, D. Vavra, D.T. Cheung, J.H. Oury, and C.M.G. Duran Aortic root geometry: pattern of differences between leaflets and sinuses of valsalva J. Heart Valve Dis. 8 1999 407 415
20. E. Rabkin, M. Aikawa, J.R. Stone, Y. Fukumoto, P. Libby, and F.J. Schoen Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves Circulation 104 2001 2525 2532
21. R.B. Hinton, and K.E. Yutzey Heart valve structure and function in development and disease D. Julius, D.E. Clapham, Annu. Rev. Physiol. 73 2011 29 46
22. M.S. Sacks, and A.P. Yoganathan Heart valve function: a biomechanical perspective Philos. Trans. R. Soc. Lond. B Biol. Sci. 362 2007 1369 1391
23. M.D. Combs, and K.E. Yutzey Heart valve development regulatory networks in development and disease Circ. Res. 105 2009 408 421
24. J.H. Chen, and C.A. Simmons Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues Circ. Res. 108 2011 1510 1524
25. R.H. Anderson, S. Webb, N.A. Brown, W. Lamers, and A. Moorman Development of the heart: (2) - septation of the atriums and ventricles Heart 89 2003 949 958
26. J. Lincoln, C.M. Alfieri, and K.E. Yutzey Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos Dev. Dyn. 230 2004 239 250
27. E. Rabkin-Aikawa, M. Farber, M. Aikawa, and F.J. Schoen Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves J. Heart Valve Dis. 13 2004 841 847
28. T.D. Camenisch, D.G.M. Molin, A. Person, R.B. Runyan, A.C. Gittenberger-de Groot, J.A. McDonald, and S.E. Klewer Temporal and distinct TGF beta ligand requirements during mouse and avian endocardial cushion morphogenesis Dev. Biol. 248 2002 170 181
29. J.T. Butcher, T.C. McQuinn, D. Sedmera, D. Turner, and R.R. Markwald Transitions in early embryonic atrioventricular valvular function correspond with changes in cushion biomechanics that are predictable by tissue composition Circ. Res. 100 2007 1503 1511
30. Y. Nakajima, T. Yamagishi, S. Hokari, and H. Nakamura Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP) Anat. Rec. 258 2000 119 127
31. L.A. Romano, and R.B. Runyan Slug is an essential target of TGF beta 2 signaling in the developing chicken heart Dev. Biol. 223 2000 91 102
32. S. Liebner, A. Cattelino, R. Gallini, N. Rudini, M. Iurlaro, S. Piccolo, and E. Dejana beta-Catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse J. Cell Biol. 166 2004 359 367
33. L.J. Ma, M.F. Lu, R.J. Schwartz, and J.F. Martin Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning Development 132 2005 5601 5611
34. R.Y. Kim, E.J. Robertson, and M.J. Solloway Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart Dev. Biol. 235 2001 449 466
35. Y. Sugi, N. Ito, G. Szebenyi, K. Myers, J.F. Fallon, T. Mikawa, and R.R. Markwald Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation Dev. Biol. 258 2003 252 263
36. L.A. Timmerman, J. Grego-Bessa, A. Raya, E. Bertran, J.M. Perez-Pomares, J. Diez, S. Aranda, S. Palomo, F. McCormick, J.C. Izpisua-Belmonte, and J.L. de la Pompa Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation Genes Dev. 18 2004 99 115
37. J. Lincoln, R. Kist, G. Scherer, and K.E. Yutzey Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development Dev. Biol. 305 2007 120 132
38. G. Del Monte, J. Grego-Bessa, A. Gonzalez-Rajal, V. Bolos, and J.L. De La Pompa Monitoring Notch1 activity in development: Evidence for a feedback regulatory loop Dev. Dyn. 236 2007 2594 2614
39. H. Zhou, W. Mak, Y. Zheng, C.R. Dunstan, and M.J. Seibel Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling J. Biol. Chem. 283 2008 1936 1945
40. F. Edom-Vovard, B. Schuler, M.A. Bonnin, M.A. Teillet, and D. Duprez Fgf4 positively regulates scleraxis and tenascin expression in chick limb tendons Dev. Biol. 247 2002 351 366
41. S. Jana, B.J. Tefft, D.B. Spoon, and R.D. Simari Scaffolds for tissue engineering of cardiac valves Acta Biomater. 10 2014 2877 2893
42. R.A. Nishimura Cardiology patient pages. Aortic valve disease Circulation 106 2002 770 772
43. J.B. Chambers Aortic stenosis Eur. J. Echocardiogr. 10 2009 i11 i19
44. J.J. Takkenberg, N.M. Rajamannan, R. Rosenhek, A.S. Kumar, J.R. Carapetis, and M.H. Yacoub The need for a global perspective on heart valve disease epidemiology. The SHVD working group on epidemiology of heart valve disease founding statement J. Heart Valve Dis. 17 2008 135 139
45. E. Marijon, P. Ou, D.S. Celermajer, B. Ferreira, A.O. Mocumbi, D. Jani, C. Paquet, S. Jacob, D. Sidi, and X. Jouven Prevalence of rheumatic heart disease detected by echocardiographic screening N. Engl. J. Med. 357 2007 470 476
46. K. Gould, C.H. Ramirez-Ronda, R.K. Holmes, and J.P. Sanford Adherence of bacteria to heart valves in vitro J. Clin. Invest. 56 1975 1364 1370
47. M.W. Cunningham T cell mimicry in inflammatory heart disease Mol. Immunol. 40 2004 1121 1127
48. R. Li, D. Mittelstein, J. Lee, K. Fang, R. Majumdar, Y. Tintut, L.L. Demer, and T.K. Hsiai A dynamic model of calcific nodule destabilization in response to monocyte- and oxidized lipid-induced matrix metalloproteinases Am. J. Physiol. Cell Physiol. 302 2012 C658 C665
49. F.J. Schoen Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering Circulation 118 2008 1864 1880
50. B.A. Carabello Evaluation and management of patients with aortic stenosis Circulation 105 2002 1746 1750
51. H.A. Braun, and W.J. Comeau The importance of high-pitched squeaking systolic murmur in the diagnosis of aortic stenosis and calcification of the aortic valve N. Engl. J. Med. 244 1951 507 509
52. A.D. Johnson Indications for and objectives of cardiac catheterization in aortic valve disease West. J. Med. 126 1977 471 473
53. P.B. Malafaya, G.A. Silva, and R.L. Reis Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications Adv. Drug Deliv. Rev. 59 2007 207 233
54. M. Biondi, F. Ungaro, F. Quaglia, and P.A. Netti Controlled drug delivery in tissue engineering Adv. Drug Deliv. Rev. 60 2008 229 242
55. M. Sokolsky-Papkov, K. Agashi, A. Olaye, K. Shakesheff, and A.J. Domb Polymer carriers for drug delivery in tissue engineering Adv. Drug Deliv. Rev. 59 2007 187 206
56. M.E. Egger, J.G. Gomez-Gutierrez, H. Hao, H.S. Zhou, and K.M. McMasters Viral-mediated gene therapy in combination with temozolomide in melanoma J. Am. Coll. Surg. 215 2012 S123
57. H.M. Viecelli, R.P. Harbottle, M. Chuah, T. VandenDriessche, C.O. Harding, and B. Thony Gene therapy for liver diseases using non-viral minicircle-DNA vector Hum. Gene Ther. 23 2012 A145 A146
58. G.D. Mogosanu, and A.M. Grumezescu Natural and synthetic polymers for wounds and burns dressing Int. J. Pharm. 463 2014 127 136
59. R. Parenteau-Bareil, R. Gauvin, and F. Berthod Collagen-based biomaterials for tissue engineering applications Materials 3 2010 1863 1887
60. V. Natarajan, N. Krithica, B. Madhan, and P.K. Sehgal Preparation and properties of tannic acid cross-linked collagen scaffold and its application in wound healing J. Biomed. Mater. Res. B Appl. Biomater. 101B 2013 560 567
61. D. Olsen, C.L. Yang, M. Bodo, R. Chang, S. Leigh, J. Baez, D. Carmichael, M. Perala, E.R. Hamalainen, M. Jarvinen, and J. Polarek Recombinant collagen and gelatin for drug delivery Adv. Drug Deliv. Rev. 55 2003 1547 1567
62. M.E. Tedder, J. Liao, B. Weed, C. Stabler, H. Zhang, A. Simionescu, and D.T. Simionescu Stabilized collagen scaffolds for heart valve tissue engineering Tissue Eng. A 15 2009 1257 1268
63. D.S. Margolis, E.W. Wu, and L.M. Truchan Axonal loss in murine peripheral nerves following exposure to recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge J. Bone Joint Surg. 95 2013 611 619
64. L.L. Chiu, L.A. Reis, and M. Radisic Controlled delivery of thymosin β4 for tissue engineering and cardiac regenerative medicine Ann. N. Y. Acad. Sci. 1269 2012 16 25
65. C. Tabele, M. Montana, C. Curti, T. Terme, P. Rathelot, S. Gensollen, and P. Vanelle Organic glues or fibrin glues from pooled plasma: efficacy. safety and potential as scaffold delivery systems J. Pharm. Pharm. Sci. 15 2012 124 140
66. P.A. Janmey, J.P. Winer, and J.W. Weisel Fibrin gels and their clinical and bioengineering applications J. R. Soc. Interface 6 2009 1 10
67. M.R. Neidert, and R.T. Tranquillo Tissue-engineered valves with commissural alignment Tissue Eng. 12 2006 891 903
68. S. Parveen, R. Misra, and S.K. Sahoo Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging Nanomed. Nanotechnol. Biol. Med. 8 2012 147 166
69. S. Jockenhoevel, G. Zund, S.P. Hoerstrup, K. Chalabi, J.S. Sachweh, L. Demircan, B.J. Messmer, and M. Turina Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering Eur. J. Cardiothorac. Surg. 19 2001 424 430
70. W.G. La, S.H. Kwon, T.J. Lee, H.S. Yang, J. Park, and B.S. Kim The effect of the delivery carrier on the quality of bone formed via bone morphogenetic protein-2 Artif. Organs 36 2012 642 647
71. G. Praveen, P.R. Sreerekha, D. Menon, S.V. Nair, and K.P. Chennazhi Fibrin nanoconstructs: a novel processing method and their use as controlled delivery agents Nanotechnology 23 2012
72. R. Pankov, and K.M. Yamada Fibronectin at a glance J. Cell Sci. 115 2002 3861 3863
73. C. Fayet, M.P. Bendeck, and A.I. Gotlieb Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury Cardiovasc. Pathol. 16 2007 203 211
74. T. Inoue, K. Egashira, T. Ide, T. Tsutsumi, Y. Monden, M. Kubo, T. Kitajima, T. Kubota, and K. Sunagawa A new drug delivery system using fibronectin-VEGF fusion is more effective and harmless than vegf alone for the therapeutic neovascularization Circulation 116 2007 72-72
75. C.C. Tate, D.A. Shear, M.C. Tate, D.R. Archer, D.G. Stein, and M.C. LaPlaca Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain J. Tissue Eng. Regen. Med. 3 2009 208 217
76. G. Dubey, and K. Mequanint Conjugation of fibronectin onto three-dimensional porous scaffolds for vascular tissue engineering applications Acta Biomater. 7 2011 1114 1125
77. M. Li, T. Cui, D.K. Mills, Y.M. Lvov, and M.J. McShane Comparison of selective attachment and growth of smooth muscle cells on gelatin- and fibronectin-coated micropatterns J. Nanosci. Nanotechnol. 5 2005 1809 1815
78. T. Ota, Y. Sawa, S. Iwai, T. Kitajima, Y. Ueda, C. Coppin, H. Matsuda, and Y. Okita Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve Ann. Thorac. Surg. 80 2005 1794 1802
79. J.F. Mano, G.A. Silva, H.S. Azevedo, P.B. Malafaya, R.A. Sousa, S.S. Silva, L.F. Boesel, J.M. Oliveira, T.C. Santos, A.P. Marques, N.M. Neves, and R.L. Reis Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends J. R. Soc. Interface 4 2007 999 1030
80. B. Duan, L.A. Hockaday, K.H. Kang, and J.T. Butcher 3D Bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels J. Biomed. Mater. Res. A 101A 2013 1255 1264
81. T. Garg, O. Singh, S. Arora, and R.S.R. Murthy Scaffold: a novel carrier for cell and drug delivery Crit. Rev. Ther. Drug Carrier Syst. 29 2012 1 63
82. Z.S. Patel, M. Yamamoto, H. Ueda, Y. Tabata, and A.G. Mikos Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2 Acta Biomater. 4 2008 1126 1138
83. Z.S. Patel, H. Ueda, M. Yamamoto, Y. Tabata, and A.G. Mikos In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds Pharm. Res. 25 2008 2370 2378
84. A. Ito, A. Mase, Y. Takizawa, M. Shinkai, H. Honda, K. Hata, M. Ueda, and T. Kobayashi Transglutaminase-mediated gelatin matrices incorporating cell adhesion factors as a biomaterial for tissue engineering J. Biosci. Bioeng. 95 2003 196 199
85. J. Nota, H. Takahashi, N. Hakuba, N. Hato, and K. Gyo Treatment of neural anosmia by topical application of basic fibroblast growth factor-gelatin hydrogel in the nasal cavity: an experimental study in mice JAMA Otolaryngol. Head Neck Surg. Study Highlights 139 2013 396 400
86. T. Hayashi Biodegradable polymers for biomedical uses Prog. Polym. Sci. 19 1994 663 702
87. Z.H. Liu, Y.P. Jiao, Y.F. Wang, C.R. Zhou, and Z.Y. Zhang Polysaccharides-based nanoparticles as drug delivery systems Adv. Drug Deliv. Rev. 60 2008 1650 1662
88. A.W. Basit, M.D. Short, and E.L. McConnell Microbiota-triggered colonic delivery: Robustness of the polysaccharide approach in the fed state in man J. Drug Target. 17 2009 64 71
89. H.J. Cho, I.S. Yoon, H.Y. Yoon, H. Koo, Y.J. Jin, S.H. Ko, J.S. Shim, K. Kim, I.C. Kwon, and D.D. Kim Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin Biomaterials 33 2012 1190 1200
90. J. Kim, Y. Park, G. Tae, K.B. Lee, S.J. Hwang, I.S. Kim, I. Noh, and K. Sun Synthesis and characterization of matrix metalloprotease sensitive-low molecular weight hyaluronic acid based hydrogels J. Mater. Sci. Mater. Med. 19 2008 3311 3318
91. B.P. Toole Hyaluronan in morphogenesis Semin. Cell Dev. Biol. 12 2001 79 87
92. D.A. Ossipov Nanostructured hyaluronic acid-based materials for active delivery to cancer Expert Opin. Drug Deliv. 7 2010 681 703
93. F. Lee, J.E. Chung, and M. Kurisawa An injectable hyaluronic acid-tyramine hydrogel system for protein delivery J. Control. Release 134 2009 186 193
94. M. Lebourg, J.R. Rochina, T. Sousa, J. Mano, and J.L.G. Ribelles Different hyaluronic acid morphology modulates primary articular chondrocyte behavior in hyaluronic acid-coated polycaprolactone scaffolds J. Biomed. Mater. Res. A 101A 2013 518 527
95. M. Halbleib, T. Skurk, C. de Luca, D. von Heimburg, and H. Hauner Tissue engineering of white adipose tissue using hyaluronic acid-based scaffolds. I: in vitro differentiation of human adipocyte precursor cells on scaffolds Biomaterials 24 2003 3125 3132
96. S. Yamane, N. Iwasaki, T. Majima, T. Funakoshi, T. Masuko, K. Harada, A. Minami, K. Monde, and S. Nishimura Feasibility of chitosan-based hyaluronic acid hybrid biomaterial for a novel scaffold in cartilage tissue engineering Biomaterials 26 2005 611 619
97. M. Eslami, N.E. Vrana, P. Zorlutuna, S. Sant, S. Jung, N. Masoumi, R.A. Khavari-Nejad, G. Javadi, and A. Khademhosseini Fiber-reinforced hydrogel scaffolds for heart valve tissue engineering J. Biomater. Appl. 29 2014 399 410
98. A. Fakhari Biomedical application of hyaluronic acid nanoparticles Department of Bioengineering, University of Kansas, Lawrence 2012 154
99. B. Duan, L.A. Hockaday, E. Kapetanovic, K.H. Kang, and J.T. Butcher Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels Acta Biomater. 9 2013 7640 7650
100. K.S. Masters, D.N. Shah, L.A. Leinwand, and K.S. Anseth Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells Biomaterials 26 2005 2517 2525
101. S. Jana, S.J. Florczyk, M. Leung, and M.Q. Zhang High-strength pristine porous chitosan scaffolds for tissue engineering J. Mater. Chem. 22 2012 6291 6299
102. P.K. Dutta, K. Rinki, and J. Dutta Chitosan: a promising biomaterial for tissue engineering scaffolds R. Jayakumar, M. Prabaharan, R.A.A. Muzzarelli, Chitosan for Biomaterials Ii 2011 45 79
103. M. George, and T.E. Abraham Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review J. Control. Release 114 2006 1 14
104. S.R. Mao, W. Sun, and T. Kissel Chitosan-based formulations for delivery of DNA and siRNA Adv. Drug Deliv. Rev. 62 2010 12 27
105. R. Riva, H. Ragelle, A. des Rieux, N. Duhem, C. Jerome, and V. Preat Chitosan and chitosan derivatives in drug delivery and tissue engineering R. Jayakumar, M. Prabaharan, R.A.A. Muzzarelli, Chitosan for Biomaterials Ii 2011 19 44
106. M.Z. Albanna, T.H. Bou-Akl, H.L. Walters, and H.W.T. Matthew Improving the mechanical properties of chitosan-based heart valve scaffolds using chitosan fibers J. Mech. Behav. Biomed. Mater. 5 2012 171 180
107. H.S. Kim, C.G. Lee, and E.Y. Lee Alginate lyase: structure, property, and application Biotechnol. Bioprocess Eng. 16 2011 843 851
108. P. Yuan, Y.T. Jia, L.K. Zhang, J.Q. Zhang, W.J. Hu, and C.Y. Wang Swelling studies and in vitro release of acemetacin and BSA from alginate gel beads crosslinked with Ca2 + or Ba2 + Materials Science Edition Journal of Wuhan University of Technology 27 2012 669 674
109. J. Leor, S. Aboulafia-Etzion, A. Dar, L. Shapiro, I.M. Barbash, A. Battler, Y. Granot, and S. Cohen Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102 2000 III56 III61
110. H.K. Tilakaratne, S.K. Hunter, M.E. Andracki, J.A. Benda, and V.G.J. Rodgers Characterizing short-term release and neovascularization potential of multi-protein growth supplement delivered via alginate hollow fiber devices Biomaterials 28 2007 89 98
111. A.M. Oprea, M.T. Nistor, M.I. Popa, C.E. Lupusoru, and C. Vasile In vitro and in vivo theophylline release from cellulose/chondroitin sulfate hydrogels Carbohydr. Polym. 90 2012 127 133
112. T.C. Flanagan, B. Wilkins, A. Black, S. Jockenhoevel, T.J. Smith, and A.S. Pandit A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications Biomaterials 27 2006 2233 2246
113. A. Sintov, N. Di-Capua, and A. Rubinstein Cross-linked chondroitin sulphate: characterization for drug delivery purposes Biomaterials 16 1995 473 478
114. H.B. Fan, Y.Y. Hu, C.L. Zhang, X.S. Li, R. Lv, L. Qin, and R. Zhu Cartilage regeneration using mesenchymal stem cells and a PLGA-gelatin/chondroitin/hyaluronate hybrid scaffold Biomaterials 27 2006 4573 4580
115. Y.J. Park, Y.M. Lee, J.Y. Lee, Y.J. Seol, C.P. Chung, and S.J. Lee Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration J. Control. Release 67 2000 385 394
116. L. Zhang, K.F. Li, W.Q. Xiao, L. Zheng, Y.M. Xiao, H.S. Fan, and X.D. Zhang Preparation of collagen-chondroitin sulfate-hyaluronic acid hybrid hydrogel scaffolds and cell compatibility in vitro Carbohydr. Polym. 84 2011 118 125
117. Q. Chen, A. Bruyneel, K. Clarke, C. Carr, and J. Czernuszka Collagen-based scaffolds for potential application of heart valve tissue engineering J. Tissue Sci. Eng. S11 003 2012 1 6
118. S. Rathbone, P. Furrer, J. Lubben, M. Zinn, and S. Cartmell Biocompatibility of polyhydroxyalkanoate as a potential material for ligament and tendon scaffold material J. Biomed. Mater. Res. A 93A 2010 1391 1403
119. E. Masaeli, M. Morshed, M.H. Nasr-Esfahani, S. Sadri, J. Hilderink, A. van Apeldoorn, C.A. van Blitterswijk, and L. Moroni Fabrication, characterization and cellular compatibility of poly(hydroxy alkanoate) composite nanofibrous scaffolds for nerve tissue engineering PLoS ONE 8 2013
120. M.Y.A. Masani, G.K.A. Parveez, A.M.D. Izawati, C.P. Lan, and A.S.N. Akmar Construction of PHB and PHBV multiple-gene vectors driven by an oil palm leaf-specific promoter Plasmid 62 2009 191 200
121. M. Avella, E. Martuscelli, and M. Raimo Review - properties of blends and composites based on poly(3-hydroxy)butyrate (PHB) and poly(3-hydroxybutyrate-hydroxyvalerate) (PHBV) copolymers J. Mater. Sci. 35 2000 523 545
122. M. Terada, and R.H. Marchessault Determination of solubility parameters for poly(3-hydroxyalkanoates) Int. J. Biol. Macromol. 25 1999 207 215
123. A. Shrivastav, S.K. Mishra, I. Pancha, D. Jain, S. Bhattacharya, S. Patel, and S. Mishra Biodegradability studies of polyhydroxyalkanoate (PHA) film produced by a marine bacteria using Jatropha biodiesel byproduct as a substrate World J. Microbiol. Biotechnol. 27 2011 1531 1541
124. M. Shah, M.I. Naseer, M.H. Choi, M.O. Kim, and S.C. Yoon Amphiphilic PHA-mPEG copolymeric nanocontainers for drug delivery: Preparation, characterization and in vitro evaluation Int. J. Pharm. 400 2010 165 175
125. H.L. Fu, S.X. Cheng, and R.X. Zhuo Biodegradable polymers for controlled release of gene delivery systems Acta Polym. Sin. 2009 97 103
126. L.Y. Qiu, and Y.H. Bae Polymer architecture and drug delivery Pharm. Res. 23 2006 1 30
127. B. Cerbai, R. Solaro, and E. Chiellini Synthesis and characterization of functional polyesters tailored for biomedical applications J. Polym. Sci. A1 Polym. Chem. 46 2008 2459 2476
128. C.S. Ha, and W.J. Cho Miscibility, properties, and biodegradability of microbial polyester containing blends Prog. Polym. Sci. 27 2002 759 809
129. K.J. Wu, C.S. Wu, and J.S. Chang Biodegradability and mechanical properties of polycaprolactone composites encapsulating phosphate-solubilizing bacterium Bacillus sp PG01 Process Biochem. 42 2007 669 675
130. C.F. Chen, H.H. Shen, T.Y. Lin, Y.J. Yu, W.C. Chen, and I.M. Chu Studies on the preparation and characterization of mpeg-polyester biodegradable bioglue for bone defect repair J. Med. Biol. Eng. 31 2011 13 17
131. E. Locatelli, and M.C. Franchini Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system J. Nanoparticle Res. 14 2012
132. T. Simon-Yarza, F.R. Formiga, E. Tamayo, B. Pelacho, F. Prosper, and M.J. Blanco-Prieto PEGylated-PLGA microparticles containing VEGF for long term drug delivery Int. J. Pharm. 440 2013 13 18
133. P. Ferruti, M.A. Marchisio, and R. Duncan Poly(amido-amine)s: biomedical applications Macromol. Rapid Commun. 23 2002 332 355
134. P. Ferruti, I. Domini, R. Barbucci, M.C. Beni, E. Dispensa, S. Sancasciani, M.A. Marchisio, and M.C. Tanzi Heparin adsorbing capacities at physiological pH of three poly(amido-amine) resins, and of poly(amido-amine)-surface-grafted glass microspheres Biomaterials 4 1983 218 221
135. F. Martello, M. Piest, J.F.J. Engbersen, and P. Ferruti Effects of branched or linear architecture of bioreducible poly(amido amine)s on their in vitro gene delivery properties J. Control. Release 164 2012 372 379
136. P. Basak, and B. Adhikari Poly (vinyl alcohol) hydrogels for pH dependent colon targeted drug delivery J. Mater. Sci. Mater. Med. 20 2009 137 146
137. T.T.N. Huynh, K. Padois, F. Sonvico, A. Rossi, F. Zani, F. Pirot, J. Doury, and F. Falson Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate Eur. J. Pharm. Biopharm. 74 2010 255 264
138. J.J. Guan, K.L. Fujimoto, M.S. Sacks, and W.R. Wagner Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications Biomaterials 26 2005 3961 3971
139. X.Y. He, Z.C. Zhai, Y.J. Wang, G. Wu, Z.W. Zheng, Q.F. Wang, and Y. Liu New method for coupling collagen on biodegradable polyurethane for biomedical application J. Appl. Polym. Sci. 126 2012 E353 E360
140. S. Ghosh Recent research and development in synthetic polymer-based drug delivery systems J. Chem. Res. Synop. 2004 241 246
141. G. Aleksieva, T. Hollweck, N. Thierfelder, U. Haas, F. Koenig, C. Fano, M. Dauner, E. Wintermantel, B. Reichart, C. Schmitz, and B. Akra Use of a special bioreactor for the cultivation of a new flexible polyurethane scaffold for aortic valve tissue engineering Biomed. Eng. Online 11 2012
142. K.C. Wollert, and H. Drexler Cell therapy for the treatment of coronary heart disease: a critical appraisal Nat. Rev. Cardiol. 7 2010 204 215
143. M.Y. Emmert, R.W. Hitchcock, and S.P. Hoerstrup Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration Adv. Drug Deliv. Rev. 69-70 2014 254 269
144. C. Gutierrez Millan, C.I. Colino Gandarillas, M.L. Sayalero Marinero, and J.M. Lanao Cell-based drug-delivery platforms Ther. Deliv. 3 2012 25 41
145. T.E. Perry, S. Kaushal, F.W.H. Sutherland, K.J. Guleserian, J. Bischoff, M. Sacks, and J.E. Mayer Bone marrow as a cell source for tissue engineering heart valves Ann. Thorac. Surg. 75 2003 761 767
146. V.L. Sales, B.A. Mettler, G.C. Engelmayr, E. Aikawa, J. Bischoff, D.P. Martin, A. Exarhopoulos, M.A. Moses, F.J. Schoen, M.S. Sacks, and J.E. Mayer Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves Tissue Eng. A 16 2010 257 267
147. F. Juthier, A. Vincentelli, J. Gaudric, D. Corseaux, O. Fouquet, C. Calet, T. Le Tourneau, V. Soenen, C. Zawadzki, O. Fabre, S. Susen, A. Prat, and B. Jude Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor J. Thorac. Cardiovasc. Surg. 131 2006 843 852
148. B. Weber, M.Y. Emmert, L. Behr, R. Schoenauer, C. Brokopp, C. Drogemuller, P. Modregger, M. Stampanoni, D. Vats, M. Rudin, W. Burzle, M. Farine, E. Mazza, T. Frauenfelder, A.C. Zannettino, G. Zund, O. Kretschmar, V. Falk, and S.P. Hoerstrup Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation Biomaterials 33 2012 4031 4043
149. S.P. Hoerstrup, A. Kadner, S. Melnitchouk, A. Trojan, K. Eid, J. Tracy, R. Sodian, J.F. Visjager, S.A. Kolb, J. Grunenfelder, G. Zund, and M.I. Turina Tissue engineering of functional trileaflet heart valves from human marrow stromal cells Circulation 106 2002 I143 I150
150. F. Colazzo, P. Sarathchandra, R.T. Smolenski, A.H. Chester, Y.T. Tseng, J.T. Czernuszka, M.H. Yacoub, and P.M. Taylor Extracellular matrix production by adipose-derived stem cells: implications for heart valve tissue engineering Biomaterials 32 2011 119 127
151. D. Schmidt, A. Mol, B. Odermatt, S. Neuenschwander, C. Breymann, M. Gossi, M. Genoni, G. Zund, and S.P. Hoerstrup Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells Tissue Eng. 12 2006 3223 3232
152. R. Sodian, P. Schaefermeier, S. Abegg-Zips, W.M. Kuebler, M. Shakibaei, S. Daebritz, J. Ziegelmueller, C. Schmitz, and B. Reichart Use of human umbilical cord blood-derived progenitor cells for tissue-engineered heart valves Ann. Thorac. Surg. 89 2010 819 828
153. D. Schmidt, J. Achermann, B. Odermatt, C. Breymann, A. Mol, M. Genoni, G. Zund, and S.P. Hoerstrup Prenatally fabricated autologous human living heart valves based on amniotic fluid-derived progenitor cells as single cell source Circulation 116 2007 I64 I70
154. D. Schmidt, A. Mol, C. Breymann, J. Achermann, B. Odermatt, M. Gossi, S. Neuenschwander, R. Pretre, M. Genoni, G. Zund, and S.P. Hoerstrup Living autologous heart valves engineered from human prenatally harvested progenitors Circulation 114 2006 I125 I131
155. D. Schmidt, J. Achermann, B. Odermatt, M. Genoni, G. Zund, and S.P. Hoerstrup Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering J. Heart Valve Dis. 17 2008 446 455 (discussion 455)
156. D. Schmidt, P.E. Dijkman, A. Driessen-Mol, R. Stenger, C. Mariani, A. Puolakka, M. Rissanen, T. Deichmann, B. Odermatt, B. Weber, M.Y. Emmert, G. Zund, F.P.T. Baaijens, and S.P. Hoerstrup Minimally-invasive implantation of living tissue engineered heart valves a comprehensive approach from autologous vascular cells to stem cells J. Am. Coll. Cardiol. 56 2010 510 520
157. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
158. F. Pierige, S. Serafini, L. Rossi, and A. Magnani Cell-based drug delivery Adv. Drug Deliv. Rev. 60 2008 286 295
159. C.D. Porada, E.D. Zanjani, and G. Almeida-Porad Adult mesenchymal stem cells: a pluripotent population with multiple applications Curr. Stem. Cell Res. Ther. 1 2006 365 369
160. A. Draube, N. Klein-Gonzalez, S. Mattheus, C. Brillant, M. Hellmich, A. Engert, and M. von Bergwelt-Baildon Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis PLoS ONE 6 2011 e18801
161. T.N. Vo, F.K. Kasper, and A.G. Mikos Strategies for controlled delivery of growth factors and cells for bone regeneration Adv. Drug Deliv. Rev. 64 2012 1292 1309
162. J.C. Sy, and M.E. Davis Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers J. Cardiovasc. Transl. Res. 3 2010 461 468
163. D.J. Mastropietro, H. Omidian, and K. Park Drug delivery applications for superporous hydrogels Expert Opin. Drug Deliv. 9 2012 71 89
164. R. Todorova Comparative analysis of the methods of drug and protein delivery for the treatment of cancer, genetic diseases and diagnostics Drug Deliv. 18 2011 586 598
165. A.E. David, J.B. Gong, B. Chertok, R.C. Domszy, C. Moon, Y.S. Park, N.S. Wang, A.J. Yang, and V.C. Yang Immobilized thermolysin for highly efficient production of low-molecular-weight protamine - an attractive cell-penetrating peptide for macromolecular drug delivery applications J. Biomed. Mater. Res. A 100A 2012 211 219
166. P. Tallury, N. Alimohammadi, and S. Kalachandra Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate Dent. Mater. 23 2007 404 409
167. H.J. Chung, and T.G. Park Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering Adv. Drug Deliv. Rev. 59 2007 249 262
168. N. Masoumi, A. Jean, J.T. Zugates, K.L. Johnson, and G.C. Engelmayr Jr. Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering J. Biomed. Mater. Res. A 101 2013 104 114
169. G.W. Ashley, J. Henise, R. Reid, and D.V. Santi Hydrogel drug delivery system with predictable and tunable drug release and degradation rates Proc. Natl. Acad. Sci. U. S. A. 110 2013 2318 2323
170. C.A. Durst, M.P. Cuchiara, E.G. Mansfield, J.L. West, and K.J. Grande-Allen Flexural characterization of cell encapsulated PEGDA hydrogels with applications for tissue engineered heart valves Acta Biomater. 7 2011 2467 2476
171. V. Gopishetty, I. Tokarev, and S. Minko Biocompatible stimuli-responsive hydrogel porous membranes via phase separation of a polyvinyl alcohol and Na-alginate intermolecular complex J. Mater. Chem. 22 2012 19482 19487
172. L.A. Hockaday, K.H. Kang, N.W. Colangelo, P.Y.C. Cheung, B. Duan, E. Malone, J. Wu, L.N. Girardi, L.J. Bonassar, H. Lipson, C.C. Chu, and J.T. Butcher Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds Biofabrication 4 2012
173. S.R. Shin, S.M. Jung, M. Zalabany, K. Kim, P. Zorlutuna, S.B. Kim, M. Nikkhah, M. Khabiry, M. Azize, J. Kong, K.T. Wan, T. Palacios, M.R. Dokmeci, H. Bae, X.S. Tang, and A. Khademhosseini Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators ACS Nano 7 2013 2369 2380
174. B.V. Slaughter, S.S. Khurshid, O.Z. Fisher, A. Khademhosseini, and N.A. Peppas Hydrogels in regenerative medicine Adv. Mater. 21 2009 3307 3329
175. L. Indolfi, F. Causa, C. Giovino, F. Ungaro, F. Quaglia, and P.A. Netti Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents J. Biomed. Mater. Res. A 97A 2011 201 211
176. M. Anindita, and P. Vikas Drug delivery: techniques for polymeric microsphere preparation Res. J. Biotechnol. 2 2007 58 63
177. B. Dhandayuthapani, Y. Yoshida, T. Maekawa, and D.S. Kumar Polymeric scaffolds in tissue engineering application: a review Int. J. Polym. Sci. 2011 2011 1 19 (Article ID 290602)
178. N.K. Varde, and D.W. Pack Microspheres for controlled release drug delivery Expert. Opin. Biol. Ther. 4 2004 35 51
179. H. Okada, and H. Toguchi Biodegradable microspheres in drug delivery Crit. Rev. Ther. Drug Carrier Syst. 12 1995 1 99
180. J.C. Sy, G. Seshadri, S.C. Yang, M. Brown, T. Oh, S. Dikalov, N. Murthy, and M.E. Davis Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction Nat. Mater. 7 2008 863 868
181. H. Hong, N.G. Dong, J.W. Shi, S. Chen, C. Guo, P. Hu, and H.X. Qi Fabrication of a novel hybrid scaffold for tissue engineered heart valve J. Huazhong Univ. Sci. Technol. Med. Sci. 29 2009 599 603
182. H. Yoon, Y. Park, and G. Kim Drug delivery system using electrospun nanofiber mats Polymer 33 2009 219 223 [Korea]
183. D.S. Katti, K.W. Robinson, F.K. Ko, and C.T. Laurencin Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters J. Biomed. Mater. Res. B Appl. Biomater. 70B 2004 286 296
184. M. Hadjiargyrou, and J.B. Chiu Enhanced composite electrospun nanofiber scaffolds for use in drug delivery Expert Opin. Drug Deliv. 5 2008 1093 1106
185. Z.G. Wang, L.S. Wan, and Z.K. Xu Immobilization of catalase on electrospun nanofibrous membranes modified with bovine serum albumin or collagen: coupling site-dependent activity and protein-dependent stability Soft Matter 5 2009 4161 4168
186. C. Deng, N.G. Dong, J.W. Shi, S. Chen, L. Xu, F. Shi, X.J. Hu, and X.Z. Zhang Application of Decellularized Scaffold Combined with Loaded Nanoparticles for Heart Valve Tissue Engineering in vitro J. Huazhong Univ. Sci. Technol. Med. Sci. 31 2011 88 93
187. S. Bamrungsap, Z.L. Zhao, T. Chen, L. Wang, C.M. Li, T. Fu, and W.H. Tan Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system Nanomedicine 7 2012 1253 1271
188. W.H. De Jong, and P.J.A. Borm Drug delivery and nanoparticles: applications and hazards Int. J. Nanomedicine 3 2008 133 149
189. B. Rahmani, S. Tzamtzis, H. Ghanbari, G. Burriesci, and A.M. Seifalian Manufacturing and hydrodynamic assessment of a novel aortic valve made of a new nanocomposite polymer J. Biomech. 45 2012 1205 1211
190. J.E. Phillips, C.A. Gersbach, and A.J. Garcia Virus-based gene therapy strategies for bone regeneration Biomaterials 28 2007 211 229
191. B. Auffinger, R. Morshed, A. Tobias, Y. Cheng, A.U. Ahmed, and M.S. Lesniak Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? Oncotarget 4 2013 378 396
192. S. Jana, B.J. Tefft, D.B. Spoon, and R.D. Simari Scaffolds for tissue engineering of cardiac valves Acta Biomater. 10 7 2014 2877 2893
193. Y.N. Chiu, R.A. Norris, G. Mahler, A. Recknagel, and J.T. Butcher Transforming growth factor beta, bone morphogenetic protein, and vascular endothelial growth factor mediate phenotype maturation and tissue remodeling by embryonic valve progenitor cells: relevance for heart valve tissue engineering Tissue Eng. A 16 2010 3375 3383
194. J.D. Kretlow, L. Klouda, and A.G. Mikos Injectable matrices and scaffolds for drug delivery in tissue engineering Adv. Drug Deliv. Rev. 59 2007 263 273
195. J.J. Kaden, S. Bickelhaupt, R. Grobholz, C.F. Vahl, S. Hagl, M. Brueckmann, K.K. Haase, C.E. Dempfle, and M. Borggrefe Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis J. Heart Valve Dis. 13 2004 560 566
196. B. Yanagawa, F. Lovren, Y. Pan, V. Garg, A. Quan, G. Tang, K.K. Singh, P.C. Shukla, N.P. Kalra, M.D. Peterson, and S. Verma miRNA-141 is a novel regulator of BMP-2-mediated calcification in aortic stenosis J. Thorac. Cardiovasc. Surg. 144 2012 256 262
197. X. Yang, X. Meng, X. Su, D.C. Mauchley, L. Ao, J.C. Cleveland Jr., and D.A. Fullerton Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2 J. Thorac. Cardiovasc. Surg. 138 2009 1008 1015
198. K. Narine, O. De Wever, D. Van Valckenborgh, K. Francois, M. Bracke, S. Desmet, M. Mareel, and G. Van Nooten Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering Tissue Eng. 12 2006 2707 2716
199. H. Song, K. Kwon, S. Lim, S.M. Kang, Y.G. Ko, Z. Xu, J.H. Chung, B.S. Kim, H. Lee, B. Joung, S. Park, D. Choi, Y. Jang, N.S. Chung, K.J. Yoo, and K.C. Hwang Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions Mol. Cells 19 2005 402 407
200. H. Haider, S. Jiang, N.M. Idris, and M. Ashraf IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair Circ. Res. 103 2008 1300 1308
201. B. Poudel-Bochmann, M. Barth, U. Boeken, A. Albert, A. Lichtenberg, and P. Akhyari The role of Insulin-like growth factor-1 in calcification of human aortic valves QSci. Proc. 2012 2012 10
202. P. Somers, R. Cornelissen, H. Thierens, and G. Van Nooten An optimized growth factor cocktail for ovine mesenchymal stem cells Growth Factors 30 2012 37 48
203. J.P. Stegemann, and R.M. Nerem Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation Ann. Biomed. Eng. 31 2003 391 402
204. J.A. Benton, H.B. Kern, L.A. Leinwand, P.D. Mariner, and K.S. Anseth Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression Arterioscler. Thromb. Vasc. Biol. 29 2009 1950 1957
205. C.I. Fisher, J. Chen, and W.D. Merryman Calcific nodule morphogenesis by heart valve interstitial cells is strain dependent Biomech. Model. Mechanobiol. 12 2013 5 17
206. B. Jian, N. Narula, Q.Y. Li, E.R. Mohler III, and R.J. Levy Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis Ann. Thorac. Surg. 75 2003 457 465 (discussion 465-456)
207. F. Bin, Y.L. Liu, X. Nin, F. Kai, L.F. Son, and X.D. Zhu Construction of tissue-engineered homograft bioprosthetic heart valves in vitro ASAIO J. 52 2006 303 309
208. E.L. Dvorin, J. Wylie-Sears, S. Kaushal, D.P. Martin, and J. Bischoff Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta(1) Tissue Eng. 9 2003 487 493
209. P. Gwanmesia, H. Ziegler, R. Eurich, M. Barth, H. Kamiya, M. Karck, A. Lichtenberg, and P. Akhyari Opposite effects of transforming growth factor-beta 1 and vascular endothelial growth factor on the degeneration of aortic valvular interstitial cell are modified by the extracellular matrix protein fibronectin: implications for heart valve engineering Tissue Eng. A 16 2010 3737 3746
210. K. Lewandowska, H.U. Choi, L.C. Rosenberg, J. Sasse, P.J. Neame, and L.A. Culp Extracellular-matrix adhesion-promoting activities of a dermatan sulfate proteoglycan-associated protein (22 K) from bovine fetal skin J. Cell Sci. 99 1991 657 668
211. J.M. Fan, Y.Y. Ng, P.A. Hill, D.J. Nikolic-Paterson, W. Mu, R.C. Atkins, and H.Y. Lan Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro Kidney Int. 56 1999 1455 1467
212. K. Kotoh, M. Nakamuta, M. Kohjima, M. Fukushima, S. Morizono, N. Kobayashi, M. Enjoji, and H. Nawata Arg-Gly-Asp (RGD) peptide ameliorates carbon tetrachloride-induced liver fibrosis via inhibition of collagen production and acceleration of collagenase activity Int. J. Mol. Med. 14 2004 1049 1053
213. V.J. Thannickal, D.Y. Lee, E.S. White, Z. Cui, J.M. Larios, R. Chacon, J.C. Horowitz, R.M. Day, and P.E. Thomas Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase J. Biol. Chem. 278 2003 12384 12389
214. A. Desmouliere, A. Geinoz, F. Gabbiani, and G. Gabbiani Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts J. Cell Biol. 122 1993 103 111
215. K. Narine, O. DeWever, K. Cathenis, M. Mareel, Y. Van Belleghem, and G. Van Nooten Transforming growth factor-beta-induced transition of fibroblasts: a model for myofibroblast procurement in tissue valve engineering J. Heart Valve Dis. 13 2004 281 289
216. P. Lijnen, and V. Petrov Transforming growth factor-beta(1)-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts Methods Find. Exp. Clin. Pharmacol. 24 2002 333 344
217. A.J.E. Appleton, C.T.G. Appleton, D.R. Boughner, and K.A. Rogers Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering Tissue Eng. A 15 2009 3889 3897
218. M.C. Cushing, P.D. Mariner, J.T. Liao, E.A. Sims, and K.S. Anseth Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells FASEB J. 22 2008 1769 1777
219. E.K. Moioli, L. Hong, and J.J. Mao Inhibition of osteogenic differentiation of human mesenchymal stem cells Wound Repair Regen. 15 2007 413 421
220. J.H. Chen, W.L.K. Chen, K.L. Sider, C.Y.Y. Yip, and C.A. Simmons beta-Catenin mediates mechanically regulated, transforming growth factor-beta 1-induced myofibroblast differentiation of aortic valve interstitial cells Arterioscler. Thromb. Vasc. Biol. 31 2011 (590-U253)
221. J.A. Benton, B.D. Fairbanks, and K.S. Anseth Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels Biomaterials 30 2009 6593 6603
222. N. Latif, P. Sarathchandra, P.S. Thomas, J. Antoniw, P. Batten, A.H. Chester, P.M. Taylor, and M.H. Yacoub Characterization of structural and signaling molecules by human valve interstitial cells and comparison to human mesenchymal stem cells J. Heart Valve Dis. 16 2007 56 66
223. S. Pedron, A.M. Kasko, C. Peinado, and K.S. Anseth Effect of heparin oligomer chain length on the activation of valvular interstitial cells Biomacromolecules 11 2010 1692 1695
224. Y. Xin, Y.M. Wang, H. Zhang, J. Li, W. Wang, Y.J. Wei, and S.S. Hu Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction Artif. Organs 34 2010 215 221
225. C. Moraes, J.H. Chen, Y. Sun, and C.A. Simmons Microfabricated arrays for high-throughput screening of cellular response to cyclic substrate deformation Lab Chip 10 2010 227 234
226. K. Balachandran, P.W. Alford, J. Wylie-Sears, J.A. Goss, A. Grosberg, J. Bischoff, E. Aikawa, R.A. Levine, and K.K. Parker Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valve Proc. Natl. Acad. Sci. U. S. A. 108 2011 19943 19948
227. H. Hong, N.G. Dong, J.W. Shi, S. Chen, C. Guo, P. Hu, and H.X. Qi Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study Artif. Organs 33 2009 554 557
228. X.F. Ye, H.Z. Wang, J.X. Zhou, H.Q. Li, J. Liu, Z. Wang, A.Q. Chen, and Q. Zhao The effect of heparin-VEGF multilayer on the biocompatibility of decellularized aortic valve with platelet and endothelial progenitor cells PLoS ONE 8 2013
229. J.A. Benton, C.A. DeForest, V. Vivekanandan, and K.S. Anseth Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function Tissue Eng. A 15 2009 3221 3230
230. S. Ramaswamy, D. Gottlieb, G.C. Engelmayr, E. Aikawa, D.E. Schmidt, D.M. Gaitan-Leon, V.L. Sales, J.E. Mayer, and M.S. Sacks The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells Biomaterials 31 2010 1114 1125
231. C.H. Wang, and S.H. Ranganath Current formulations and techniques of drug/gene delivery for targeted therapy and tissue engineering Curr. Pharm. Des. 16 2010 2296 2297
232. M. Gutova, J. Najbauer, G. Cherryholmes, M. Edmiston, S.U. Kim, M. Chen, and K.S. Aboody Targeted therapy of metastatic melanoma using neural stem cell-based drug delivery Mol. Ther. 17 2009 S105
233. L. De Laporte, and L.D. Shea Matrices and scaffolds for DNA delivery in tissue engineering Adv. Drug Deliv. Rev. 59 2007 292 307
234. V. Labhasetwar Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery Curr. Opin. Biotechnol. 16 2005 674 680
235. S. Jin, and K.M. Ye Nanoparticle-mediated drug delivery and gene therapy Biotechnol. Prog. 23 2007 32 41
236. S.J. Stachelek, C. Song, I. Alferiev, S. Defelice, X. Cui, J.M. Connolly, R.W. Bianco, and R.J. Levy Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants Gene Ther. 11 2004 15 24
237. C.X. Song, L.H. Zhang, J. Yang, S.J. Stachelek, and R.J. Levy Animal study of intravascular gene therapy based on polyurethane implantable devices Zhongguo Yi Xue Ke Xue Yuan Xue Bao 28 2006 682 685
238. G. Acharya, R.A. Hopkins, and C.H. Lee Advanced polymeric matrix for valvular complications J. Biomed. Mater. Res. A 100A 2012 1151 1159
239. N. Ma, F. Oery, W. Li, T. Guping, G. Steinhoff, and C. Stamm Polymer based DNA matrices for heart valve tissue engineering Thorac. Cardiovasc. Surg. 53 2005 43 48
240. G. Schwarzmann, and P. Sefrin Thrombogenicity of central vein catheters - comparison of 2 polyurethane catheters Infusionsther. Transfusionsmed. 20 1993 148 156
241. I.S. Alferiev, and I. Fishbein Activated polyurethane modified with latent thiol groups Biomaterials 23 2002 4753 4758
242. S.J. Stachelek, I. Alferiev, J.M. Connolly, M. Sacks, R.P. Hebbel, R. Bianco, and R.J. Levy Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo Ann. Thorac. Surg. 81 2006 47 56
243. W.C. Broaddus, G.T. Gillies, and J. Kucharczyk Minimally invasive procedures - advances in image-guided delivery of drug and cell therapies into the central nervous system Neuroimaging Clin. N. Am. 11 2001 727-+
244. M. Kajimoto, T. Shimono, K. Hirano, Y. Miyake, Y. Sawada, N. Kato, H. Hirata, K. Imanaka-Yoshida, M. Nishikawa, T. Yoshida, H. Shimpo, T. Horiuchi, and K. Miyamoto Development of a new method for endovascular aortic repair - combination therapy of cell transplantation and stent grafts with a drug delivery system Circulation 114 2006 I378 I383
245. E.F. Rocnik, E. van der Veer, H. Cao, R.A. Hegele, and J.G. Pickering Functional linkage between the endoplasmic reticulum protein Hsp47 and procollagen expression in human vascular smooth muscle cells J. Biol. Chem. 277 2002 38571 38578
246. V. Mironov, V. Kasyanov, A. Nagy-Mehesz, R. Moreno, Z. Hajdu, T. Trusk, I. Ozolanta, M. Murovska, Y. Wu, H. Yao, V. Beachley, X. Wen, A. Bradshaw, R. Visconti, R. Norris, and R. Markwald Tissue engineering of heart valve leaflet by self-assembly of tissue spheroids biofabricated from human fat tissue derived stem cells FMBE Proceedings 2010 Springer Munich, Germany
247. T.C. Lee, Y.D. Zhao, D.W. Courtman, and D.J. Stewart Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase Circulation 101 2000 2345 2348
248. N.M. Rajamannan Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS(-/-) null mice J. Cell. Biochem. 113 2012 1623 1634
249. X.Q. Chen, L.L. Chen, L. Fan, J. Fang, Z.Y. Chen, and W.W. Li Stem cells with FGF4-bFGF fused gene enhances the expression of bFGF and improves myocardial repair in rats Biochem. Biophys. Res. Commun. 447 2014 145 151
250. X.Y. Zhu, X.Z. Zhang, L. Xu, X.Y. Zhong, Q. Ding, and Y.X. Chen Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue Biochem. Biophys. Res. Commun. 379 2009 1084 1090
251. J.M. Tang, J.N. Wang, L. Zhang, F. Zheng, J.Y. Yang, X. Kong, L.Y. Guo, L. Chen, Y.Z. Huang, Y. Wan, and S.Y. Chen VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart Cardiovasc. Res. 91 2011 402 411
252. Y.L. Tang, Y. Tang, Y.C. Zhang, K. Qian, L. Shen, and M.I. Phillips Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector J. Am. Coll. Cardiol. 46 2005 1339 1350
253. H. GuangJie Studies on Tissue Engineering Heart Valve Construction with Human Endothelial Progenitor Cells Transfected by Ad.FnCBD64 2006 Department of Cardiothoracic Surgery, Second Military Medical University Shanghai
254. N.G. Dong, Y.M. Qiu, and J.W. Shi Application of transforming growth factor-beta(1) on construction of tissue engineering heart valves: experimental in vitro Zhonghua Yi Xue Za Zhi 87 2007 1622 1626
255. L.P. Brewster, E.M. Brey, and H.P. Greisler Cardiovascular gene delivery: The good road is awaiting Adv. Drug Deliv. Rev. 58 2006 604 629
256. G.X. Wang, Z.G. Li, C.J. Tang, D.Y. Du, Y. Shen, J.C.-M. Lee, and Q.S. Yu VEGF-Transfected Human Endothelial Cell Coating on Stents Promotes Re-endothelization and Inhibits In-stent Restenosis C.T. Lim, J.C.T. GOh, IFMBE Proceedings 2010 Springerlink Singapore 1196 1199
257. C. Tang, G. Wang, X. Wu, Z. Li, Y. Shen, J.C. Lee, and Q. Yu The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents J. Vasc. Surg. 53 2011 461 471
258. P. Diaz-Herraez, E. Garbayo, T. Simon-Yarza, F.R. Formiga, F. Prosper, and M.J. Blanco-Prieto Adipose-derived stem cells combined with neuregulin-1 delivery systems for heart tissue engineering Eur. J. Pharm. Biopharm. 85 2013 143 150